Federal crackdown uncovers $149 million in healthcare-related COVID-19 fraud
By
Kimberly Bonvissuto
Apr 21, 2022
The Department of Justice on Wednesday announced criminal charges against 21 companies in nine federal districts for an alleged $149 million in pandemic-related healthcare fraud schemes.
Most COVID-19-related EUAs not supported by high-quality evidence
Dec 30, 2021
For drugs and vaccines, the emergency use authorizations were mostly supported by randomized clinical trials.
LeadingAge launches stimulus bill facility impact calculator
By
Amy Novotney
Apr 09, 2020
LeadingAge introduced two tools Wednesday to help long-term care operators better understand what help is available to them through the two federal COVID-19 relief bills recently signed into law: the Families...
More than a third of seniors will wait to get COVID-19 vaccine: survey
By
Amy Novotney
Dec 15, 2020
As COVID-19 vaccinations among high-risk populations begin this week, more than one in three seniors (36%) now say they plan to wait to get the vaccine, according to a new survey from insurance firm GoHealth....
Prolonged SARS-CoV-2 risk varies across immunosuppressive conditions
Jan 31, 2024
Severely immunocompromised individuals had greater SARS-CoV-2 evolution and a higher risk for developing resistance against therapeutic mAbs.
Two-thirds of survivors of the most severe COVID-19 face impairment at one year
Apr 26, 2024
Physical, psychiatric and cognitive problems were seen in those discharged to long-term acute care hospitals.
Cognitive symptoms common with post-COVID-19 condition
Feb 15, 2024
Symptoms were linked to increased odds of at least moderate interference with functioning and lower odds of full-time employment.
Veterans report low rates of adverse events with mRNA vaccines
Jun 16, 2022
Rates were slightly higher at 42 days for those receiving the Pfizer versus Moderna vaccine.
Risk for psychiatric illness up in early postacute COVID-19 phase
Jun 14, 2022
Risks for new-onset psychiatric diagnoses and anxiety disorders, but not mood disorders, increased in the early postacute phase.
Study looks at extent of residual lung abnormalities after COVID-19 hospitalization
Dec 02, 2022
The posthospitalization prevalence of residual lung abnormalities was estimated at 11.7% in sensitivity analyses.